These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6239468)

  • 1. [Cell surface changes after high-dosage progesterone treatment in endometrial carcinoma].
    Szarvas Z; Zsolnai B
    Zentralbl Gynakol; 1984; 106(14):1010-7. PubMed ID: 6239468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of long-term high-dose progesterone (Depo-Provera) therapy on endometrial carcinoma].
    Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
    Morphol Igazsagugyi Orv Sz; 1985 Oct; 25(4):253-60. PubMed ID: 2933583
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surface changes in endometrial cancer under the effect of large doses of progestogen (Depo-Provera)].
    Szarvas Z; Zsolnai B
    Morphol Igazsagugyi Orv Sz; 1984 Apr; 24(2):92-9. PubMed ID: 6717452
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of progestogen (Depo-Provera) on annulate lamellae in endometrial carcinoma.
    Szarvas Z; Zsolnai B
    Acta Chir Hung; 1984; 25(4):269-76. PubMed ID: 6240879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
    Thurzó L
    Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochemistry of cell surface sialoglycoconjugates in endometrial adenocarcinoma. Effects of medroxyprogesterone therapy.
    Barni S; Gerzeli G; Novelli G
    Appl Pathol; 1984; 2(3):135-45. PubMed ID: 6544600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface ultrastructural response of the human uterine lining epithelium to hormonal environment. A scanning electron microscopic study.
    Ferenczy A
    Acta Cytol; 1977; 21(4):566-72. PubMed ID: 269610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
    Ohta M; Takeda A; Ninagawa T; Tomoda Y
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)].
    Beliaeva LA; Bukhvalov IB; Zheleznov BI; Raĭkhlin NT
    Arkh Patol; 1982; 44(4):18-25. PubMed ID: 7082195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the uterine endometrium. Surface ultrastructure as an indicator of malignant potential and effect of treatment.
    Stenbäck F
    Scan Electron Microsc; 1982; (Pt 4):1577-85. PubMed ID: 7184139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous, high-dose progestogen treatment of endometrial cancer.
    Szarvas Z; Zsolnai B; Gimes G; Hidvégi J
    Gynecol Obstet Invest; 1987; 24(4):262-6. PubMed ID: 2962910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of degrees of differentiation of endometrial cancer].
    Szarvas Z
    Morphol Igazsagugyi Orv Sz; 1980 Oct; 20(4):256-60. PubMed ID: 7266521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.
    Kauppila A; Isotalo H; Kivinen S; Stenbäck F; Vihko R
    Int J Cancer; 1985 Feb; 35(2):157-63. PubMed ID: 3156097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
    Piver MS; Lele S; Barlow JJ
    Obstet Gynecol; 1980 Sep; 56(3):370-2. PubMed ID: 7422177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tamoxifen on ultrastructure of endometrial carcinoma.
    Amano N; Ochiai K; Tohtake T; Terashima Y; Kato J
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):670-4. PubMed ID: 3585111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.